Johnson And Johnson is part of the healthcare sector and drug manufacturers industry. The company CEO is Alex Gorsky. Johnson and Johnson is a holding company, which is engaged in the research and development, manufacture and sale of products in the health care field within its Consumer, Pharmaceutical and Medical Devices segments.
Previous Intraday Trading Performance:
The JNJ stock showed a previous change of 0.57% with an open at 135.22 and a close of 135.98. It reached an intraday high of 136.35 and a low of 134.75.
The stock has a market cap of $362.1b with 2.7b shares outstanding, of which the float is 2.7b shares. Trading volume reached 5,682,071 shares compared to its average volume of 6,121,531 shares. Based on the current average volume and close price, the trading liquidity is good.
Historical Trading Performance:
Over the last five trading days, Johnson And Johnson shares returned -0.12% and in the past 30 trading days it returned -1.81%. Over three months, it changed 5.81%. In one year it has changed 6.03% and within that year its 52-week high was 148.99 and its 52-week low was 118.62. JNJ stock is 14.63% above its 52 Week Low.
Our calculations show a 200 day moving average of 133.83 and a 50 day moving average of 136.25. Currently JNJ stock is trading 1.61% above its 200 day moving average and may be a good opportunity to buy.
The last annual fiscal EPS for the company was reported at 5.61 that ended on 31st of December 2018, which according to the previous close, that is a PE of 24.24. Based on 8 analyst estimates, the consensus EPS for the next quarter is 2.04. The TTM EPS is 8.18, which comes to a TTM PE of 16.62. Historically, the PE high was 310.40 and the PE low was 14.30. If the stock reached its PE low, that would represent a price of 117.00, which is a decrease of -13.96%.
The dividend per share is currently 3.60, which is a dividend yield of 2.65%. Also, the payout ratio is 44.01%, therefore the dividend is safe according to our calculations.
Base on our calculations, the intrinsic value per share is 210.62, which means it is possibly undervalued and has a margin of safety of 35.44%
Indicators to Watch:
Based on the latest filings, there is 0.10% of insider ownership and 103.10% of institutional ownership. Short-interest is 12,267,355, which is 0.46% of shares outstanding. The short-interest ratio or days-to-cover ratio is 1.83. This stock has some short interest, but it may be normal and no cause for concern if long the position.
The current calculated beta is 0.67
Based on last reported financials, the company’s return on equity is 25.51%, return on assets is 9.86%, profit margin is 17.75%, price-to-sales is 5.85 and price-to-book is 6.06.
All scores are out of six:
1 :Valuation Score
4 :Past Performance Score
3 :Financial Strength Score
2 :Future Growth Score
5 :Dividend Score
3 :Overall Score